Evidence map›Paper›PMID 21256154›Full record

ReviewPharmacology & therapeutics2011

MicroRNAs: Meta-controllers of gene expression in synaptic activity emerge as genetic and diagnostic markers of human disease.

Stephanie Ceman, Julie Saugstad

Abstract readReview
In one paragraph

Review in Pharmacology & therapeutics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. miR-155: An Important Role in Inflammation Response.Journal of immunology research · 2022
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  11. Article
  12. Down-Regulation of MicroRNA-133b Suppresses Apoptosis of Lens Epithelial Cell by Up-Regulating BCL2L2 in Age-Related Cataracts.Medical science monitor : international medical journal of experimental and clinical research · 2016
    Article
  13. MicroRNAs and drug-induced kidney injury.Pharmacology & therapeutics · 2016
    Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. MicroRNA-132 may play a role in coexistence of depression and cardiovascular disease: a hypothesis.Medical science monitor : international medical journal of experimental and clinical research · 2013
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Stephanie CemanUniversity of Illinois, Department of Cell & Developmental Biology, Urbana, IL 61801, USA.
Julie Saugstad
Legacy Health · US

Funding

Role for MicroRNAs in Ischemic ToleranceR01NS064270 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI SAUGSTAD, JULIE ANNE · 2010 to 2012
$908k
Role of MicroRNAs in Ischemic ToleranceR21NS054220 · NINDS · LEGACY EMANUEL HOSPITAL AND HEALTH CENTER · PI SAUGSTAD, JULIE ANNE · 2006 to 2007
$378k
NINDS NIH HHS R01 NS064270NINDS NIH HHS R01NS064270NINDS NIH HHS R21 NS054220NINDS NIH HHS R21NS054220
6 · The paper itself

Abstract

MicroRNAs are members of the non-protein-coding family of RNAs. They serve as regulators of gene expression by modulating the translation and/or stability of messenger RNA targets. The discovery of microRNAs has revolutionized the field of cell biology, and has permanently altered the prevailing view of a linear relationship between gene and protein expression. The increased complexity of gene regulation is both exciting and daunting, as emerging evidence supports a pervasive role for microRNAs in virtually every cellular process. This review briefly describes microRNA processing and formation of RNA-induced silencing complexes, with a focus on the role of RNA binding proteins in this process. We also discuss mechanisms for microRNA-mediated regulation of translation, particularly in dendritic spine formation and function, and the role of microRNAs in synaptic plasticity. We then discuss the evidence for altered microRNA function in cognitive brain disorders, and the effect of gene mutations revealed by single nucleotide polymorphism analysis on altered microRNA function and human disease. Further, we present evidence that altered microRNA expression in circulating fluids such as plasma/serum can correlate with, and serve as, novel diagnostic biomarkers of human disease.

Indexed as

Gene Expression RegulationBiomarkersBrain DiseasesCognition DisordersDendritic SpinesHumansMicroRNAsNeuronal PlasticityPolymorphism, Single NucleotideRNA-Binding ProteinsRNA-Induced Silencing ComplexRNA, MessengerRNA StabilitySynapsesBiomarkersMicroRNAsRNA-Binding ProteinsRNA-Induced Silencing ComplexRNA, Messenger

Identifiers

PMID21256154
PMCPMC3043141
OpenAlexW2083599686

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.